title: [Clinical study of smoking cessation clinic subjects].
abstract: The Cigarette-associated diseases will be decreased only by stopping smoking. At a smoking cessation clinic, we evaluated 22 subjects for smoking cessation after a three-month smoking cessation program. The program was completed by 20 subjects, or 90%, of whom 15, or 68%, quit smoking. Varenicline tartrate was used to treat 90% of subject, of whom 8, or 40%, suffered nausea. This was treated using an anti-nausea agent, which relieved symptoms immediately.
authors.affiliation: Department of Otolaryngology, Showa University Yokohama Northern Hospital, Yokohama.
authors.forename: Miki
authors.initials: M
authors.lastname: Shino
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Saito
authors.forename: Shuhei
authors.initials: S
authors.lastname: Takiguchi
authors.forename: Yukiomi
authors.initials: Y
authors.lastname: Kushihashi
authors.forename: Miyuki
authors.initials: M
authors.lastname: Suzuki
authors.forename: Yoshihiro
authors.initials: Y
authors.lastname: Yamada
authors.forename: Yoshiyuki
authors.initials: Y
authors.lastname: Kadokura
authors.forename: Masato
authors.initials: M
authors.lastname: Kano
authors.forename: Harumi
authors.initials: H
authors.lastname: Suzaki
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001552:Benzazepines / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009538:Nicotine / Q000008:administration & dosage / Q000009:adverse effects; D018722:Nicotinic Agonists / Q000009:adverse effects / Q000627:therapeutic use; D010044:Outpatient Clinics, Hospital; D010045:Outpatients; D011810:Quinoxalines / Q000009:adverse effects / Q000627:therapeutic use; D016540:Smoking Cessation; D000068580:Varenicline
chemical_list: D001552:Benzazepines; D018722:Nicotinic Agonists; D011810:Quinoxalines; D009538:Nicotine; D000068580:Varenicline